BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21567392)

  • 1. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.
    Bhatnagar S; Mittal A; Gupta SK; Kumar A
    J Cell Physiol; 2012 Mar; 227(3):1042-51. PubMed ID: 21567392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.
    Dogra C; Changotra H; Wedhas N; Qin X; Wergedal JE; Kumar A
    FASEB J; 2007 Jun; 21(8):1857-69. PubMed ID: 17314137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK and TRAF6 regulate skeletal muscle atrophy.
    Kumar A; Bhatnagar S; Paul PK
    Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):233-9. PubMed ID: 22366923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-allyl cysteine inhibits TNFα-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules.
    Dutt V; Saini V; Gupta P; Kaur N; Bala M; Gujar R; Grewal A; Gupta S; Dua A; Mittal A
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):895-906. PubMed ID: 29288771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.
    Yarar-Fisher C; Bickel CS; Kelly NA; Stec MJ; Windham ST; McLain AB; Oster RA; Bamman MM
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E754-61. PubMed ID: 26931128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.
    Hindi SM; Mishra V; Bhatnagar S; Tajrishi MM; Ogura Y; Yan Z; Burkly LC; Zheng TS; Kumar A
    FASEB J; 2014 Mar; 28(3):1398-411. PubMed ID: 24327607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.
    Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A
    J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.
    Cid-Díaz T; Santos-Zas I; González-Sánchez J; Gurriarán-Rodríguez U; Mosteiro CS; Casabiell X; García-Caballero T; Mouly V; Pazos Y; Camiña JP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):974-990. PubMed ID: 28675664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
    Li H; Mittal A; Paul PK; Kumar M; Srivastava DS; Tyagi SC; Kumar A
    J Biol Chem; 2009 Feb; 284(7):4439-50. PubMed ID: 19074147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.
    Tajrishi MM; Sato S; Shin J; Zheng TS; Burkly LC; Kumar A
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1219-1224. PubMed ID: 24680686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
    Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
    EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
    He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
    Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A
    J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
    Sandri M
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee MK; Choi JW; Choi YH; Nam TJ
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30544821
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lee MK; Choi YH; Nam TJ
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.
    McClung JM; Judge AR; Powers SK; Yan Z
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C542-9. PubMed ID: 19955483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF- α and IFN-s-dependent muscle decay is linked to NF-κB- and STAT-1α-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes.
    Pijet B; Pijet M; Litwiniuk A; Gajewska M; Pająk B; Orzechowski A
    Mediators Inflamm; 2013; 2013():171437. PubMed ID: 24453411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
    Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
    Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.